Ratings agency Moody’s has downgraded the Co-operative Bank’s debt rating to “junk” status.
Read the rest here: AUDIO: Co-op ratings downgrade
The Top Penny Stocks newsletter for active penny stocks investors looking for penny stocks and pink sheet stocks
Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...
Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday
Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...
UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...
Eurozone crisis live: Japan's strong growth figures... PM Shinzo Abe's stimulus package could generate feelgood factor needed to end two decades of stagnant growthPhillip Inman
Vancouver, British Columbia – February 22, 2013 – Sirona Biochem Corp. (TSX-V: SBM, OTCQX:
SRBCF, Frankfurt: ZSB), (the “Company”) announced today a non-brokered private
placement of up to 27,000,000 units of the Company at a price of US$0.10 per
unit (each a “Unit”) for gross
proceeds of up to US$2,700,000 (the “Private
Placement”) led by U.S. Life Sciences Investor Moody Capital Solutions,
“Strong science coupled with
attractive unmet markets makes Sirona Biochem an excellent investment for us,”
said Tim Moody, President and Founder of Moody Capital. “We are impressed with
Sirona Biochem’s scientific programs and are confident in the commercial
potential of their compounds,” added Mr. Moody.
“Moody Capital has provided
funding for a number of successful life sciences companies and their support is
a testament to the value of our programs and technology platform,” said Sirona
Biochem Chief Executive Officer, Neil Belenkie. “We are thrilled by Moody
Capital’s enthusiasm for our technology and vision,” Mr. Belenkie added.
Each Unit will consist of one
common share of the Company (a “Share”)
and one transferable share purchase warrant (a “Warrant”).
Shares in the US credit rating agency Moody’s fall 7.7% in trading in New York on Friday amid fears of legal action surrounding rating agencies.
Visit link: Moody’s shares fall amid legal fears